NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Ilaria Schiavetto
Ospedale Niguarda Ca' Granda, Milan - / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5277466
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Ilaria Schiavetto's MOST POPULAR ARTICLES
1-)
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase …S Siena, L Crino, M Danova, S Del Prete, S Cascinu, S Salvagni, ...Annals of oncology 21 (3), 655-661, 20101192010
2-)
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical resultsS Secondino, M Zecca, L Licitra, A Gurrado, I Schiavetto, P Bossi, L Locati, ...Annals of oncology 23 (2), 435-441, 2012692012
3-)
Treatment of metastatic neuroendocrine carcinomas based on WHO classificationS Artale, L Giannetta, G Cerea, D Maggioni, P Pedrazzoli, I Schiavetto, ...Anticancer research 25 (6C), 4463-4469, 2005452005
4-)
Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumorD Montagna, I Turin, R Schiavo, E Montini, N Zaffaroni, R Villa, ...Cytotherapy 14 (1), 80-90, 2012402012
5-)
A phase II randomized open-label study of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with weekly paclitaxel versus weekly paclitaxel in patients …J Liu, IL Ray-Coquard, F Selle, A Poveda, D Cibula, HW Hirte, ...Journal of Clinical Oncology 32 (15_suppl), 5519-5519, 2014262014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept